ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,519,941 | -23.1% | 8,556,925 | +5.1% | 0.00% | 0.0% |
| Q2 2023 | $17,590,528 | -47.5% | 8,143,763 | -48.9% | 0.00% | -50.0% |
| Q1 2023 | $33,492,090 | +251.5% | 15,948,614 | +266.5% | 0.00% | +100.0% |
| Q4 2022 | $9,529,582 | -26.0% | 4,351,407 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $12,882,000 | +8.2% | 4,293,756 | +2.0% | 0.00% | 0.0% |
| Q2 2022 | $11,910,000 | -46.6% | 4,208,437 | +0.9% | 0.00% | -50.0% |
| Q1 2022 | $22,307,000 | -28.4% | 4,169,369 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $31,139,000 | -15.6% | 4,168,601 | +2.6% | 0.00% | -33.3% |
| Q3 2021 | $36,895,000 | +351.1% | 4,063,293 | +142.5% | 0.00% | +200.0% |
| Q2 2021 | $8,178,000 | +16.0% | 1,675,880 | +5.8% | 0.00% | 0.0% |
| Q1 2021 | $7,052,000 | +19.0% | 1,584,684 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $5,928,000 | +30.8% | 1,527,818 | +8.9% | 0.00% | – |
| Q3 2020 | $4,531,000 | -27.3% | 1,402,874 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $6,229,000 | +58.6% | 1,402,874 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,928,000 | +91.7% | 1,402,874 | +185.5% | 0.00% | – |
| Q4 2019 | $2,049,000 | +19.1% | 491,449 | 0.0% | 0.00% | – |
| Q3 2019 | $1,720,000 | – | 491,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
| Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
| Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
| VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
| Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
| FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
| Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
| Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
| Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |